'This isn’t just real estate. It’s about patients': Bob Coughlin talks new JLL role



After nearly 14 years representing the Bay State’s biopharmaceutical industry as the CEO of MassBio, Bob Coughlin took a step back from the limelight in 2021, and has spent the past three years focused on life science companies in a different way.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *